1
TITLE: Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study  Full Text
AUTHORS: Santoni, Matteo; Myint, Zin W.; Buettner, Thomas; Takeshita, Hideki; Okada, Yohei; Lam, Elaine T.; Gilbert, Danielle; Kueronya, Zsofia; Tural, Deniz; Pichler, Renate; Grande, Enrique; Crabb, Simon J.; Kemp, Robert; Massari, Francesco; Scagliarini, Sarah; Iacovelli, Roberto; Vau, Nuno; Basso, Umberto; Maruzzo, Marco; Molina Cerrillo, Javier; Galli, Luca; Bamias, Aristotelis; De Giorgi, Ugo; Zucali, Paolo Andrea; Rizzo, Mimma; Seront, Emmanuel; Popovic, Lazar; Caffo, Orazio; Buti, Sebastiano; Kanesvaran, Ravindran; Kopecky, Jindrich; Kucharz, Jakub; Zeppellini, Annalisa; Fiala, Ondrej; Landmesser, Johannes; Ansari, Jawaher; Giannatempo, Patrizia; Rizzo, Alessandro; Zabalza, Ignacio Ortego; Monteiro, Fernando Sabino M.; Battelli, Nicola; Calabro, Fabio; Porta, Camillo; ...More
PUBLISHED: 2023, SOURCE: CANCER IMMUNOLOGY IMMUNOTHERAPY
INDEXED IN: Scopus WOS